铁和其调节剂:癌症和阿尔茨海默氏症的提高目标
Gourav Singh1, Prashant Kesharwani2, Gireesh Kumar Singh3
1Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, India.
Bioorganic & medicinal chemistry
|January 3, 2024
概括
铁,一种与铁和氧化应激相关的细胞死亡过程,在癌症和阿尔茨海默氏症等疾病中至关重要. 了解它的诱导和抑制为新的治疗策略提供了机会.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
背景情况:
- 铁亡是一种受调节的细胞死亡 (RCD) 形式,涉及铁过载和脂质过氧化.
- 它在生物化学,功能和形态学方面从根本上与亡和亡有所不同.
- 铁亡与癌症和阿尔茨海默氏症等疾病的发病有关.
研究的目的:
- 系统地审查ferroptosis诱导和抑制的机制.
- 为了探索调节铁亡的药物.
- 突出铁死在疾病病因学中的作用,并确定治疗点.
主要方法:
- 对铁灭症诱导途径 (例如,抑制系统Xc,GPX4) 的文献综述.
- 关于铁灭抑制途径 (例如,阻断脂质过氧化) 的文献综述.
- 探索诱导或抑制铁亡的药物.
主要成果:
- 铁生可以通过抑制Xc系统,谷氨耗尽,铁化或GPX4抑制来诱导.
- 抑制包括通过各种途径阻止脂质过氧化.
- 独特的生化和形态特征使铁死与其他RCD类型区别开来.
结论:
- 了解铁灭机制是开发治疗铁相关疾病的关键.
- 向铁亡途径为癌症和阿尔茨海默病提供了新的治疗途径.
- 进一步研究铁死在疾病中的调节作用是有必要的.
相关概念视频
Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Electron Transport Chain: Complex I and II
13.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.5K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K


